In the News
LACRIFILL® Canalicular Gel is changing clinical practice and changing lives when it comes to dry eye treatment. Latest NewsNordic Group B.V. Through its Subsidiary Nordic Pharma, Inc. (U.S.), Announces LACRIFILL® Canalicular Gel Inclusion in New Dry Eye Workshop (DEWS) III Management and Therapy Report From The Tear Film and Ocular Surface Society (TFOS) in American Journal of Ophthalmology
Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Presenting Patient Data and Patient Experience Study for LACRIFILL® Canalicular Gel, a Novel Therapy for Dry Eye, at the American Society of Cataract and Refractive Surgery Annual Meeting
Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Announces Details of LACRIFILL® Canalicular Gel Poster Presentation At SECO 2025
Come meet with us at these 2025 Meetings and Conferences
ASOPRS Fall Scientific Symposium
October 16-17 | Orlando, FL
AAO & ASORN
October 17-20 | Orlando, FL
Vance Thompson Vision - Event
25-Oct | Bozeman, MT
Ocular Surgery News
November 7-9 | New York, NY
Intrepid/New Tech Support
November 14-16 | Nashville, TN
Cedars Aspens
December 4-6 | Scottsdale, AZ